Inflammatory bowel disease in children

J. Gryboski, C. Hillemeier

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Inflammatory bowel disease must be considered in the differential diagnosis of abdominal pain, weight loss, or rectal bleeding in children of any age. Colitis in the infant is more often caused by allergy to milk or soy protein but may be indistinguishable from ulcerative colitis and should be treated with hypoallergenic formulas such as Nutramigen or Pregestamil before other modes of therapy are initiated. Growth is of prime concern in children both at the onset and during therapy. Suppression of disease activity often requires steroids which are known to inhibit growth. The goals of management, therefore, aim for administration of steroids in doses and of a duration to control disease with no expectation for growth. Gradual tapering and elimination of steroids is usually followed by resumption or catch-up of linear growth. Short stature is more often associated with Crohn's disease than with ulcerative colitis, and although no metabolic abnormalities are identified, anorexia with hypocaloric intake is its usual cause. Surgical resection of the colon is curative of ulcerative colitis, and there should be no hesitation in recommending surgery for the patient who has severe growth failure or disease which has been unresponsive to therapy for 2 years. However, surgery is recommended cautiously in children with Crohn's disease because of a 50 to 75 per cent incidence of recurrence after operation. Furthermore, half or less of children with growth failure show no increase in growth after operation. Extracolonic manifestations of inflammatory bowel disease in children occur as in adults. The most significant are arthritis and erythema nodosum. Although considerable advances have been made in the physiology, diagnosis, and therapy of inflammatory bowel disease, there is as yet no medical cure available. The prognosis in children often carries prolonged periods of disability and in those with ulcerative colitis, a cancer risk increased over that of the adult.

Original languageEnglish (US)
Pages (from-to)1185-1202
Number of pages18
JournalMedical Clinics of North America
Volume64
Issue number6
DOIs
StatePublished - Jan 1 1980

Fingerprint

Inflammatory Bowel Diseases
Ulcerative Colitis
Growth
Steroids
Crohn Disease
Erythema Nodosum
Soybean Proteins
Milk Proteins
Anorexia
Colitis
Therapeutics
Abdominal Pain
Arthritis
Weight Loss
Hypersensitivity
Colon
Differential Diagnosis
Hemorrhage
Recurrence
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Gryboski, J. ; Hillemeier, C. / Inflammatory bowel disease in children. In: Medical Clinics of North America. 1980 ; Vol. 64, No. 6. pp. 1185-1202.
@article{c0bb0119f93e40efa48a27d0623ea834,
title = "Inflammatory bowel disease in children",
abstract = "Inflammatory bowel disease must be considered in the differential diagnosis of abdominal pain, weight loss, or rectal bleeding in children of any age. Colitis in the infant is more often caused by allergy to milk or soy protein but may be indistinguishable from ulcerative colitis and should be treated with hypoallergenic formulas such as Nutramigen or Pregestamil before other modes of therapy are initiated. Growth is of prime concern in children both at the onset and during therapy. Suppression of disease activity often requires steroids which are known to inhibit growth. The goals of management, therefore, aim for administration of steroids in doses and of a duration to control disease with no expectation for growth. Gradual tapering and elimination of steroids is usually followed by resumption or catch-up of linear growth. Short stature is more often associated with Crohn's disease than with ulcerative colitis, and although no metabolic abnormalities are identified, anorexia with hypocaloric intake is its usual cause. Surgical resection of the colon is curative of ulcerative colitis, and there should be no hesitation in recommending surgery for the patient who has severe growth failure or disease which has been unresponsive to therapy for 2 years. However, surgery is recommended cautiously in children with Crohn's disease because of a 50 to 75 per cent incidence of recurrence after operation. Furthermore, half or less of children with growth failure show no increase in growth after operation. Extracolonic manifestations of inflammatory bowel disease in children occur as in adults. The most significant are arthritis and erythema nodosum. Although considerable advances have been made in the physiology, diagnosis, and therapy of inflammatory bowel disease, there is as yet no medical cure available. The prognosis in children often carries prolonged periods of disability and in those with ulcerative colitis, a cancer risk increased over that of the adult.",
author = "J. Gryboski and C. Hillemeier",
year = "1980",
month = "1",
day = "1",
doi = "10.1016/S0025-7125(16)31563-2",
language = "English (US)",
volume = "64",
pages = "1185--1202",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "6",

}

Inflammatory bowel disease in children. / Gryboski, J.; Hillemeier, C.

In: Medical Clinics of North America, Vol. 64, No. 6, 01.01.1980, p. 1185-1202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inflammatory bowel disease in children

AU - Gryboski, J.

AU - Hillemeier, C.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - Inflammatory bowel disease must be considered in the differential diagnosis of abdominal pain, weight loss, or rectal bleeding in children of any age. Colitis in the infant is more often caused by allergy to milk or soy protein but may be indistinguishable from ulcerative colitis and should be treated with hypoallergenic formulas such as Nutramigen or Pregestamil before other modes of therapy are initiated. Growth is of prime concern in children both at the onset and during therapy. Suppression of disease activity often requires steroids which are known to inhibit growth. The goals of management, therefore, aim for administration of steroids in doses and of a duration to control disease with no expectation for growth. Gradual tapering and elimination of steroids is usually followed by resumption or catch-up of linear growth. Short stature is more often associated with Crohn's disease than with ulcerative colitis, and although no metabolic abnormalities are identified, anorexia with hypocaloric intake is its usual cause. Surgical resection of the colon is curative of ulcerative colitis, and there should be no hesitation in recommending surgery for the patient who has severe growth failure or disease which has been unresponsive to therapy for 2 years. However, surgery is recommended cautiously in children with Crohn's disease because of a 50 to 75 per cent incidence of recurrence after operation. Furthermore, half or less of children with growth failure show no increase in growth after operation. Extracolonic manifestations of inflammatory bowel disease in children occur as in adults. The most significant are arthritis and erythema nodosum. Although considerable advances have been made in the physiology, diagnosis, and therapy of inflammatory bowel disease, there is as yet no medical cure available. The prognosis in children often carries prolonged periods of disability and in those with ulcerative colitis, a cancer risk increased over that of the adult.

AB - Inflammatory bowel disease must be considered in the differential diagnosis of abdominal pain, weight loss, or rectal bleeding in children of any age. Colitis in the infant is more often caused by allergy to milk or soy protein but may be indistinguishable from ulcerative colitis and should be treated with hypoallergenic formulas such as Nutramigen or Pregestamil before other modes of therapy are initiated. Growth is of prime concern in children both at the onset and during therapy. Suppression of disease activity often requires steroids which are known to inhibit growth. The goals of management, therefore, aim for administration of steroids in doses and of a duration to control disease with no expectation for growth. Gradual tapering and elimination of steroids is usually followed by resumption or catch-up of linear growth. Short stature is more often associated with Crohn's disease than with ulcerative colitis, and although no metabolic abnormalities are identified, anorexia with hypocaloric intake is its usual cause. Surgical resection of the colon is curative of ulcerative colitis, and there should be no hesitation in recommending surgery for the patient who has severe growth failure or disease which has been unresponsive to therapy for 2 years. However, surgery is recommended cautiously in children with Crohn's disease because of a 50 to 75 per cent incidence of recurrence after operation. Furthermore, half or less of children with growth failure show no increase in growth after operation. Extracolonic manifestations of inflammatory bowel disease in children occur as in adults. The most significant are arthritis and erythema nodosum. Although considerable advances have been made in the physiology, diagnosis, and therapy of inflammatory bowel disease, there is as yet no medical cure available. The prognosis in children often carries prolonged periods of disability and in those with ulcerative colitis, a cancer risk increased over that of the adult.

UR - http://www.scopus.com/inward/record.url?scp=0019218784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019218784&partnerID=8YFLogxK

U2 - 10.1016/S0025-7125(16)31563-2

DO - 10.1016/S0025-7125(16)31563-2

M3 - Article

C2 - 7464341

AN - SCOPUS:0019218784

VL - 64

SP - 1185

EP - 1202

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 6

ER -